LobbyingAtrium Health - Formerly Known As Carolinas Healthcare System lobbying by quarter
Atrium Health - Formerly Known As Carolinas Healthcare System's latest lobbying report covers Q4 2025, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Labor Issues/Antitrust/Workplace.
Atrium Health - Formerly Known As Carolinas Healthcare System
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $68.7K | 1 |
| Q1 2023 | $176.4K | 1 |
| Q2 2023 | $170K | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $117K | 1 |
| Q2 2024 | $210K | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $340K | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$55.6K · 2 reports
- Labor, antitrust and workplace$55.6K · 2 reports
- Medicare and Medicaid$55.6K · 2 reports
- Pharmacy$55.6K · 2 reports
- Budget and appropriations$11.5K · 1 reports
- Telecommunications$11.5K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
- Health & Human Services, Dept of (HHS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAtrium Health-Formerly Known As Carolinas Healthcare System | $1.1M | 13 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 01/20for Q4 2025 | In-house | Under $5,000 |
| 25/10/13for Q3 2025 | In-house | Under $5,000 |
| 25/07/21for Q2 2025 | In-house | Under $5,000 |
| 25/04/17for Q1 2025 | In-house | $340K |
| 25/01/17for Q4 2024 | In-house | Under $5,000 |
| 24/10/18for Q3 2024 | In-house | Under $5,000 |
| 24/07/16for Q2 2024 | In-house | $210K |
| 24/04/19for Q1 2024 | In-house | $117K |
| 24/01/22for Q4 2023 | In-house | Under $5,000 |
| 23/10/20for Q3 2023 | In-house | Under $5,000 |
| 23/07/19for Q2 2023 | In-house | $170K |
| 23/04/20for Q1 2023 | In-house | $176.4K |
| 23/01/15for Q4 2022 | In-house | $68.7K |